Condition: Plexiform Neurofibroma · Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
This study aims to demonstrate that in subjects with symptomatic, inoperable plexiform neurofibromas associated with neurofibromatosis type 1, TQ-B3234 capsules significantly improve the objective response rate at Week 24 compared to placebo.
This description comes directly from the study's public registry record.
Qingfeng Li, Doctor · 021 53315108 · dr.liqingfeng@shsmu.edu.cn
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Anhui Medical University | Hefei, Anhui, China | Not Yet Recruiting |
| Peking Union Medical College Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Xuanwu Hospital Capital Medical University | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Beijing Tiantan Hospital, Capital Medical University | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Peking University Third Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| The Southwest Hospital of Amu | Chongqing, Chongqing Municipality, China | Recruiting |
| The First Affiliated Hospital of Fujan Medical University | Fuzhou, Fujian, China | Not Yet Recruiting |
| Gansu Provincial Cancer Hospital | Lanzhou, Gansu, China | Not Yet Recruiting |
| Sun Yat-Sen University Cancer Center | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Dermatology Hospital of Southern Medical University (Guangdong Provincial Dermatology Hospital / Guangdong Center for the Prevention and Control of Sexually Transmitted Diseases and Leprosy | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Guangxi Medical University Cancer Hospital （ Guangxi Cancer InstituteGuangxi Cancer Hospital & Medical University Oncology School & Cancer Center） | Nanning, Guangxi, China | Not Yet Recruiting |
| Guizhou Provincial People's Hospital | Guiyang, Guizhou, China | Not Yet Recruiting |
+ 17 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07407803